Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
Breast cancer (BC) is the most prevalent cancer in women. BC is heterogeneous, with distinct phenotypical and morphological characteristics. These are based on their gene expression profiles, which divide BC into different subtypes, among which the triple-negative breast cancer (TNBC) subtype is the...
Main Authors: | Elizabeth Varghese, Samson Mathews Samuel, Alena Líšková, Marek Samec, Peter Kubatka, Dietrich Büsselberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/8/2252 |
Similar Items
-
Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
by: Samson Mathews Samuel, et al.
Published: (2020-09-01) -
Flavonoids in Cancer and Apoptosis
by: Mariam Abotaleb, et al.
Published: (2018-12-01) -
Enzymatic Metabolism of Flavonoids by Gut Microbiota and Its Impact on Gastrointestinal Cancer
by: Raghad Khalid AL-Ishaq, et al.
Published: (2021-08-01) -
The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
by: Elizabeth Varghese, et al.
Published: (2018-09-01) -
Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
by: Aranka Brockmueller, et al.
Published: (2021-01-01)